Table 4 Secondary outcome measures at baseline and at day seven for both feet combined
Baseline | Day 7 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Outcome | N | Median | IQRa | Min | Max | N | Median | IQRa | Min | Max | p valueb |
Inflammation score | 56 | 4.3 | 3.4 | 1 | 22 | 57 | 0.5 | 1.5 | 0 | 12 | <0.001 |
Visual scales | |||||||||||
Intensity of spontaneous pain | 60 | 3 | 1 | 1 | 4 | 60 | 0 | 1 | 0 | 4 | <0.001 |
Intensity of itching | 60 | 3 | 1 | 1 | 4 | 60 | 0 | 1 | 0 | 3 | <0.001 |
Itch-related sleep disturbance | 60 | 2 | 1 | 1 | 4 | 60 | 0 | 1 | 0 | 4 | <0.001 |
Pain-related sleep disturbance | 60 | 2 | 1 | 1 | 4 | 60 | 0 | 0 | 0 | 3 | <0.001 |
Degree of mobility impairment | 52 | 2 | 1 | 1 | 4 | 59 | 0 | 1 | 0 | 4 | <0.001 |